Physician profile
Michael B Tracy
NPI 1770778805
$6,293.12
in general payments reported to CMS, 2019-2025
44 companies · $323 in 2025
The $323 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $638 · 2021: $1,141 · 2022: $1,342 · 2023: $1,329 · 2024: $783 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,435.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,216.84 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Abbott Laboratories | $857.04 | 2019-2024 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $607.89 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Collegium Pharmaceutical, INC. | $424.86 | 2020-2023 | Belbuca |
| Scilex Pharmaceuticals INC. | $362.09 | 2019-2024 | Ztlido |
| Orexo US, INC. | $361.57 | 2019-2023 | Zubsolv |
| Upsher-Smith Laboratories LLC | $251.94 | 2020-2023 | |
| Allergan, INC. | $224.57 | 2019-2021 | |
| Amgen INC. | $168.44 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $151.06 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $150.80 | 2021 | |
| Pfizer INC. | $148.81 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.64 | 2020-2022 | |
| Zyla Life Sciences, INC. | $120.71 | 2019 | |
| Almatica Pharma LLC | $117.37 | 2020-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.